P53MVA

p53 MVA vaccine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for P53MVA, covering 2024-10-08 to 2024-10-08. Get the full timeline:

Most recent: Clinical Trial Update: P53MVA and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer [Phase 2]

See pricing